Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
4.880
+0.030 (0.62%)
Jun 30, 2026, 12:20 PM EDT - Market open
Bausch Health Companies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1,258 | 87.43 | -50.17 | -461.13 | -212 | -937 |
Depreciation & Amortization | 870.11 | 880.11 | 882.88 | 953.97 | 1,394 | 1,552 |
Stock-Based Compensation | 166.37 | 157.37 | 104.52 | 99.62 | 126 | 128 |
Other Adjustments | 173.01 | 217.11 | 337.96 | 640.76 | -66 | 1,178 |
Change in Receivables | -59.63 | -97.63 | -150.52 | -147.17 | -57 | -229 |
Changes in Inventories | 7.26 | -8.74 | -186.05 | -243.02 | -198 | -16 |
Changes in Accounts Payable | -106.37 | -55.37 | 248.77 | 119.25 | -75 | 121 |
Changes in Other Operating Activities | -284.29 | -160.29 | -74.56 | -183.4 | -1,640 | -371 |
Operating Cash Flow | 1,039 | 1,020 | 1,113 | 778.87 | -728 | 1,426 |
Operating Cash Flow Growth | -6.63% | -8.34% | 42.88% | - | - | 28.35% |
Capital Expenditures | -283.24 | -289.24 | -234.83 | -162.27 | -218 | -269 |
Purchases of Intangible Assets | -36.29 | -7.29 | -2.09 | -43.02 | -50 | -14 |
Purchases of Investments | -5.01 | -8.01 | -8.36 | -20.38 | -17 | -19 |
Proceeds from Sale of Investments | 2.83 | 5.83 | 9.76 | 19.62 | 22 | 15 |
Payments for Business Acquisitions | -136.63 | -148.63 | -94.77 | -1,426 | -45 | - |
Proceeds from Business Divestments | - | 5.1 | 4.88 | 3.77 | 5 | 669 |
Other Investing Activities | 7.74 | 8.74 | 9.06 | 9.81 | - | 27 |
Investing Cash Flow | -442.5 | -433.5 | -316.36 | -1,619 | -303 | 409 |
Long-Term Debt Issued | 10,441 | 7,689 | 460.6 | 2,484 | 6,836 | 2,100 |
Long-Term Debt Repaid | -10,842 | -8,153 | -1,017 | -1,291 | -7,846 | -3,440 |
Net Long-Term Debt Issued (Repaid) | -401.1 | -464.1 | -556.77 | 1,193 | -1,010 | -1,340 |
Issuance of Common Stock | - | - | - | - | 675 | - |
Net Common Stock Issued (Repurchased) | - | - | - | - | 675 | - |
Other Financing Activities | -93.5 | -76.5 | -48.08 | -80 | -139 | -173 |
Financing Cash Flow | -494.6 | -540.6 | -604.85 | 1,113 | -474 | -1,513 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 19.44 | 44.44 | -25.09 | 6.79 | -23 | -19 |
Net Cash Flow | 121.34 | 90.34 | 166.54 | 280 | -1,528 | 303 |
Free Cash Flow | 755.75 | 730.75 | 878 | 616.61 | -946 | 1,157 |
Free Cash Flow Growth | 3.42% | -16.77% | 42.39% | - | - | 43.02% |
FCF Margin | 6.36% | 7.12% | 9.12% | 7.04% | -11.64% | 13.72% |
Free Cash Flow Per Share | 2.02 | 1.95 | 2.39 | 1.69 | -2.61 | 3.22 |
Levered Free Cash Flow | -1,380 | 59.37 | 33.44 | 1,086 | -1,972 | -1,271 |
Unlevered Free Cash Flow | 3,640 | 3,400 | 4,395 | 901.83 | -575.11 | 1,505 |